Stonehage Fleming Financial Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,000
| Closed | -$465K | – | 267 |
|
|
2024
Q1 | $465K | Buy |
+20,000
| New | +$465K | 0.03% | 75 |
|
|
2023
Q4 | – | Sell |
-14,000
| Closed | -$285K | – | 259 |
|
|
2023
Q3 | $285K | Buy |
+14,000
| New | +$285K | 0.03% | 132 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$465K | – | 222 |
|
|
2023
Q1 | $465K | Hold |
20,000
| – | – | 0.03% | 75 |
|
|
2022
Q4 | $503K | Sell |
20,000
-10,000
| -33% | -$252K | 0.04% | 71 |
|
|
2022
Q3 | $791K | Hold |
30,000
| – | – | 0.06% | 49 |
|
|
2022
Q2 | $867K | Buy |
30,000
+4,000
| +15% | +$116K | 0.03% | 76 |
|
|
2022
Q1 | $895K | Buy |
26,000
+4,500
| +21% | +$155K | 0.03% | 83 |
|
|
2021
Q4 | $941K | Buy |
+21,500
| New | +$941K | 0.03% | 87 |
|